ACELRX PHARMACEUTICALS INC (ACRX) Earnings History & Surprises
NASDAQ:ACRX • US00444T2096
0.86 USD
+0.06 (+7.5%)
At close: Jan 9, 2024
0.8719 USD
+0.01 (+1.38%)
After Hours: 1/9/2024, 8:00:00 PM
Past quarterly earnings results for ACELRX PHARMACEUTICALS INC (ACRX), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Release DateMar 28, 2024
PeriodQ4 / 2023
EPS Estimate-$0.19
Revenue Estimate286.62K
Last Reported
Release DateNov 8, 2023
PeriodQ3 / 2023
EPS Reported-$0.08
EPS Surprise 71.99%
Revenue Surprise -10.53%
Beat Rate
50%
EPS and Revenuebeats vs estimates
Quarterly Earnings Results
EPS & Revenue History (USD)
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2023 | -0.08 | -0.29 | 71.99% | 91.49% | 120K | 134.13K | -10.53% | - |
| Q2 2023 | -0.40 | -0.54 | 26.01% | 66.67% | 250K | 76.5K | 226.80% | - |
| Q1 2023 | -0.75 | -1.42 | 47.10% | 37.50% | 612K | -100.00% | - | |
| Q4 2022 | -1.00 | -0.52 | -92.23% | 16.67% | 250K | 4.59M | -94.55% | - |
| Q3 2022 | -0.94 | -1.22 | 23.20% | 32.86% | 637.5K | -100.00% | -100.00% | |
| Q2 2022 | -1.20 | -1.53 | 21.57% | 25.00% | 561K | -100.00% | -100.00% | |
| Q1 2022 | -1.20 | -1.22 | 1.96% | 25.00% | 561K | -100.00% | -100.00% | |
| Q4 2021 | -1.20 | -1.43 | 15.97% | 40.00% | 1.887M | -100.00% | -100.00% | |
| Q3 2021 | -1.40 | -1.43 | 1.96% | 30.00% | 1.86M | 1.938M | -4.02% | 35.77% |
| Q2 2021 | -1.60 | -1.56 | -2.30% | - | 440K | 1.845M | -76.15% | -84.93% |
| Q1 2021 | -1.60 | -1.70 | 5.88% | 60.00% | 510K | 1.079M | -52.73% | 30.77% |
| Q4 2020 | -2.00 | -2.11 | 5.12% | - | 740K | 1.764M | -58.05% | - |
| Q3 2020 | -2.00 | -1.68 | -18.84% | - | 1.37M | 2.891M | -52.61% | - |
| Q2 2020 | -1.60 | -2.81 | 42.96% | - | 2.92M | 2.064M | 41.47% | - |
| Q1 2020 | -4.00 | -3.47 | -15.34% | - | 390K | 1.894M | -79.41% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
3
Average EPS beat (4)
13.22%
Max EPS beat (4)
71.99%
Min EPS beat (4)
-92.23%
Revenue beat statistics
Revenue beat (4)
1
Average Revenue beat (4)
5.43%
Max Revenue beat (4)
226.80%
Min Revenue beat (4)
-100.00%
Analysis
In the last 4 quarters, ACRX has beaten EPS estimates in 3 out of 4 releases
ACRX has beaten revenue estimates in 1 out of the last 4 releases
In the last 4 quarters, ACRX has beaten the EPS estimates by 13.2% on average.
In the last 4 quarters, ACRX has beaten the revenue estimates by 5.4% on average.
ACELRX PHARMACEUTICALS INC / ACRX Earnings FAQ
What is the most recent earnings date for ACRX stock?
ACELRX PHARMACEUTICALS INC (ACRX) last reported earnings on 11/8/2023.
Can you provide information on whether ACELRX PHARMACEUTICALS INC beat earnings estimates in the last quarter?
ACELRX PHARMACEUTICALS INC (ACRX) beat EPS estimates and missed revenue estimates in the most recent quarter.
How often does ACELRX PHARMACEUTICALS INC (ACRX) beat earnings estimates?
In the last 4 quarters, ACELRX PHARMACEUTICALS INC (ACRX) has beaten EPS estimates in 3 out of 4 releases.